Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Syngene International Limited
  6. Summary
    539268   INE398R01022

SYNGENE INTERNATIONAL LIMITED

(539268)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
09/14/2021 09/15/2021 09/16/2021 09/17/2021 09/20/2021 Date
667.1 666.2 659.75 647.25 643.05 Last
147772 115087 1856639 57200 50202 Volume
-0.37% -0.13% -0.97% -1.89% -0.65% Change
Estimated financial data (e)
Sales 2022 25 504 M 346 M 346 M
Net income 2022 4 408 M 59,9 M 59,9 M
Net cash position 2022 4 104 M 55,7 M 55,7 M
P/E ratio 2022 58,8x
Yield 2022 0,07%
Sales 2023 30 090 M 409 M 409 M
Net income 2023 6 229 M 84,6 M 84,6 M
Net cash position 2023 7 681 M 104 M 104 M
P/E ratio 2023 43,8x
Yield 2023 0,14%
Capitalization 255 B 3 462 M 3 462 M
EV / Sales 2022 9,84x
EV / Sales 2023 8,22x
Nbr of Employees 5 437
Free-Float 28,7%
More Financials
Company
Syngene International Limited is a contract research company. The Company is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies. Its services include discovery chemistry and biology services, toxicology, pharmaceutical development, process development/manufacture of intermediates, active pharmaceutical... 
More about the company
Ratings of Syngene International Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SYNGENE INTERNATIONAL LIMITED
07/20SYNGENE INTERNATIONAL : Consolidated Net Profit Climbs in Fiscal Q1
MT
07/20Syngene International Limited Announces Resignation of John M M Shaw from the..
CI
07/20Syngene International Limited Reports Earnings Results for the First Quarter ..
CI
06/22Syngene International Limited Appoints Dr. Kush Parmar as an Additional Direc..
CI
05/26DYADIC INTERNATIONAL : Syngene to Join Forces for COVID-19 Vaccine Production
MT
05/26SYNGENE INTERNATIONAL : Dyadic announces development of COVID-19 Vaccine in Indi..
AQ
05/26Dyadic International, Inc. Enters into Collaboration with Syngene Internation..
CI
04/28BIOCON : Syngene targets delivering 500,000 vials of remdesivir in India as COVI..
RE
04/28SYNGENE INTERNATIONAL : Posts Higher Profit in January-March
MT
04/27Syngene International Limited Reports Earnings Results for the Fourth Quarter..
CI
04/27Syngene International Limited Announces No Dividend for the Financial Year 20..
CI
04/01SYNGENE INTERNATIONAL : Picks Minority Stake in HR Kaveri
MT
01/20Syngene International Limited Reports Earnings Results for the Third Quarter ..
CI
2020Syngene International Limited to Undertake Scaled Manufacture Feasibility Stu..
CI
2020SYNGENE INTERNATIONAL : Arm Collaborates with US Firm for Therapeutic Discovery ..
MT
More news
News in other languages on SYNGENE INTERNATIONAL LIMITED

- No features available -

More news
Chart SYNGENE INTERNATIONAL LIMITED
Duration : Period :
Syngene International Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYNGENE INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 643,05 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Jonathan Hunt Chief Executive Officer, MD & Executive Director
Sibaji Biswas Chief Financial Officer
Kiran Mazumdar-Shaw Non-Executive Chairman
Mahesh K Bhalgat Chief Operating Officer
Priyadarshini I. Mahapatra Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNGENE INTERNATIONAL LIMITED0.54%3 483
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420